Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VSL#3 in Alcohol-Related Liver Disease and Alcohol Use Disorder
NCT05007470Active, not recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Jan 2022
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Randomised, double-blind trial in alcohol use disorder (AUD) and alcoholic liver disease (ALD), sponsored by University of California, Los Angeles. Primary endpoints: Rate of Abstinence at 6 months, Maddrey's Discriminant Function at 6 months and 1 more. Started Jan 2022; status: active, not recruiting.
02
Conditions
alcohol use disorder (AUD)alcoholic liver disease (ALD)
Beyond the preview
Go deeper on NCT05007470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05007470.